Shares of Japan’s Eisai tumble after EU rejects Alzheimer’s drug
EU regulator cites brain swelling risks, impacting Eisai and Biogen, and sparking concerns over global sales and market perception…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
European Union drug regulator
AstraZeneca’s COVID prevention drug application gets EU fast-track assessment
An accelerated assessment aims to speed up the European Medicines Agency’s (EMA) review of a market authorisation application